Global 3D Cell Culture Market Overview
3D cell culture or three-dimensional culture systems is one of the fastest-growing experimental approaches in life sciences. It is referred to as a process of growing cells in their native context or in vivo environment. 3D cell culture system application is increasing with advancements in cell imaging and analytical systems. It has proven to be helpful systems for various research and discoveries as it overcomes the drawbacks of 2D cell cultures and more effectively stimulates cell morphology, adhesion, and proliferation. It served as a model for various experimental therapy studies such as radiotherapy, chemotherapy, and cell- and antibody-based immunotherapy. The market for 3D cell culture is anticipated to grow with a combination of factors, including increasing emphasis on developing alternatives to animal testing, increasing incidence of chronic diseases, increasing emphasis on personalized medicine, the mounting burden of other lifestyle diseases, and the availability of funding for research and drug development.
According to Value Market Research, the global 3D cell culture market size was valued at about USD 1.99 billion in 2022 and is estimated to grow at a CAGR of around 15.6% during the forecast period 2023 to 2030.
The market is experiencing fast-paced growth owing to the current COVID-19 pandemic and growing demand from cancer research institutes, laboratories, and pharmaceutical companies. The growing demand for efficient culture to study drug doses is again pushing the market demand uphill. Advances in 3D cell culture have aided several aspects of research, such as controlling the 3D microenvironment, fabrication of scaffolds for 3D culture, imaging of cellular interactions with the 3D microenvironment, and the large-scale manufacture of cells. However, the inadequate infrastructure and support from the government for 3D cell-based research and the high cost of cell biology research are factors restraining the growth of this market during the forecast period.
Key market players are adopting organic and inorganic growth strategies such as acquisitions and expansions to maintain their position in the market. Major market companies focus on novel product launches and collaborations with other companies to gain market presence. Thermo Fisher Scientific, Inc. (US), Marck KGaA (Germany) Coming incorporated (US) Lonza (Switzerland), Avantor inc (US) and others. are key players operating in the global 3D cell culture market.
In this research report, the 3D cell culture market is segmented by product, application, end-use, and region.
Analysis, By Product
Scaffold-based platforms are a dominant product segment in the global 3D cell culture market. Scaffold-based platforms are highly preferred due to their structural rigidity, ease of imaging, simple assay protocol, availability of attachment points, and mechanical and biochemical properties that can be easily modified as per the need of the application.
Analysis, By Application
Cancer research held a maximum share in the global 3D cell culture market. Researchers worldwide are studying more intricate details about preventing, diagnosing, treating, and surviving cancer. Researchers are also working to reduce the potential long-term side effects and chronic side effects of treatment. The stem cell research segment is predicted to grow at a faster pace. Increasing focus on developing personalized medicines, increasing demand for biologics, and technological advancement in stem cell therapeutics are steering stem cell research segment growth.
Analysis, By End User
Biotechnology & pharmaceutical companies are prime users of 3D cell culture technology. The segment makes robust use of 3D cell culture to test for the success and efficiency of their discoveries. Booming drug discovery activities worldwide, increased funding support from the government, and the rising adoption of new advanced technologies for the fast process is augmenting segment growth. The contract research laboratories and academic institutes segment is estimated to witness significant growth attributed to outsourcing research and a rise in mergers and acquisitions among research institutes and pharmaceutical companies.
Analysis, By Region
Based on region, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is ruling the global 3D cell culture market. The region is most promising for 3D cell culture growth. North America is foremost at adopting state of the art technology, is blessed with the presence of a skilled and specialized workforce, has a strong life science research infrastructure, and is the base of many prominent research organizations and institutes and pharmaceutical companies. The Asia Pacific and Europe is emerging as a potential contributor. Increased spending in drug and life science research and significant initiatives towards adopting new advanced technologies will drive the growth of these regions.
Market Segmentation covered in the Report:
By Product
- Scaffold-based 30 Cell Cultures
- Scaffold-free 30 Cell Cultures
- Microdics-based 30 Cell Cuttures
- Magnetic & Soprinted 3D Cell Cultures
By Application
- Cancer & Stem Cell Research
- Drug Discovery & Toxicology Testing
- Tissue Engineering & Regenerative Medicine
By End user
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Cosmetics Industry
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.